250 – PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

250 - PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

August 12, 2026

250 – PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

Share

Show Notes

PIC/S has issued its first major update to its qualification and validation recommendations in nearly 20 years. PI 006-4 replaces PI 006-3 from 2007 and brings the document much closer to how qualification and validation are approached today.

In this video, I walk through where PI 006-4 fits within the broader GMP framework, how it relates to EU Annex 15, and the sections I think are most worth paying attention to.

A few of the major themes include a much stronger emphasis on quality risk management and lifecycle thinking, more explicit expectations around statistics, sampling, variability, and process capability, a move away from treating three validation batches as a default answer, and clearer discussion of traditional validation, continuous process verification (CPV), hybrid approaches, and ongoing process verification (OPV).

The goal isn't to suggest that all of these concepts are brand new. Many have been developing across the industry for years. What is interesting is seeing how PIC/S has now pulled them together into an updated recommendation that reflects current qualification and validation thinking.

Chapters

00:00 Big Update Overview

01:02 Who PIC/S Serves

01:28 Annex 15 Relationship

02:12 Scope and Exclusions

02:39 Why Update Now

04:05 Four Key Changes

04:47 Risk and Lifecycle Shift

06:43 Statistics and Sampling

07:48 Rethinking the Three-Batch Rule

08:30 Ongoing Process Verification

09:11 Traditional, CPV and Hybrid Approaches

10:45 Key Takeaways

About Subhi

Subhi Saadeh is a quality professional, consultant, auditor, and trainer who specializes in drug-device combination products, medical devices, pharmaceutical quality systems, supplier quality, and lifecycle management. Through Let’s Combinate, he helps pharmaceutical and medical device teams bridge the gap between drug and device quality, regulatory expectations, and practical execution.

Connect With Let’s Combinate

Website:
https://www.letscombinate.com

Schedule an intro call:
https://calendly.com/letscombinate/let-s-combinate-intro-session

LinkedIn:
https://www.linkedin.com/in/subhi-saadeh-1169aa21

Apple Podcasts:
https://podcasts.apple.com/us/podcast/lets-combinate-drugs-devices/id1589285792

Spotify:
https://open.spotify.com/show/71wYadhCrfLsdYTVachpD2

Documents Discussed

PIC/S PI 006-4 — Recommendations on Qualification and Validation (2026)
https://picscheme.org/docview/11277

PIC/S PI 006-3 — Validation Master Plan, IQ/OQ, Non-Sterile Process Validation & Cleaning Validation (2007)
https://picscheme.org/docview/3447

EMA / PIC/S Concept Paper — Revision of Annex 15: Qualification and Validation (2026)
https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-guidelines-good-manufacturing-practice-medicinal-products-annex-15-qualification-validation_en.pdf

PIC/S Publications Page
https://picscheme.org/en/publications

Join Our news Letter

By signing up, you agree to receive email from this podcast.

Recent Episodes

August 12, 2026

250 – PIC/S PI 006-4 (2026): What Changed in Qualification & Validation?

August 5, 2026

249 – The Best Audit Advice Nobody Told Me

July 29, 2026

248 – What Is a Quality Unit? QA vs. QC Explained

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.